Efficacy and tolerability of sorafenib in desmoid-type fibromatosis: A need to review dose
European Journal of Cancer · 2023
DOI: 10.1016/j.ejca.2023.03.017 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Vikas Garg und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, BRAIRCH, AIIMS, Delhi, India. Electronic address: vg18007@gmail.com. Hauptthemen laut MEDLINE: Antineoplastic Agents, Desmoid Tumors, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, BRAIRCH, AIIMS, Delhi, India. Electronic address: vg18007@gmail.com.
- Department of Medical Oncology, BRAIRCH, AIIMS, Delhi, India. Electronic address: bharathbg01@gmail.com.
- Department of Medical Oncology, BRAIRCH, AIIMS, Delhi, India. Electronic address: samdoc_mamc@yahoo.com.
- Department of Biostatistics, AIIMS, Delhi, India. Electronic address: aduaiims@gmail.com.
- Department of Pathology, AIIMS, Delhi, India. Electronic address: adawad@gmail.com.
- Department of Radiodiagnosis, BRAIRCH, AIIMS, Delhi, India. Electronic address: drektadhamija.aiims@gmail.com.
Zitieren
APA
Garg, V., Gangadharaiah, B. B., Rastogi, S., Upadhyay, A., Barwad, A., Dhamija, E., & Gamangatti, S. (2023). Efficacy and tolerability of sorafenib in desmoid-type fibromatosis: A need to review dose. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.03.017
Vancouver
Garg V, Gangadharaiah BB, Rastogi S, Upadhyay A, Barwad A, Dhamija E, et al. Efficacy and tolerability of sorafenib in desmoid-type fibromatosis: A need to review dose. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.03.017
BibTeX
@article{Garg2023,
author = {Garg, Vikas and Gangadharaiah, Bharath B and Rastogi, Sameer and Upadhyay, Ashish and Barwad, Adarsh and Dhamija, Ekta and Gamangatti, Shivanand},
title = {Efficacy and tolerability of sorafenib in desmoid-type fibromatosis: A need to review dose},
journal = {European Journal of Cancer},
year = {2023},
doi = {10.1016/j.ejca.2023.03.017}
}
EUVIMED